Analysis of the expression level and methylation of tumor protein p53, phosphatase and tensin homolog and mutS homolog 2 in N-methyl-N-nitrosourea-induced thymic lymphoma in C57BL/6 mice

Huo,Xueyun; Li,Zhenkun; Zhang,Shuangyue; Li,Changlong; Guo,Meng; Lu,Jing; Lv,Jianyi; Du,Xiaoyan; Chen,Zhenwen

doi:10.3892/ol.2017.6721

Analysis of the expression level and methylation of tumor protein p53, phosphatase and tensin homolog and mutS homolog 2 in N-methyl-N-nitrosourea-induced thymic lymphoma in C57BL/6 mice

Authors:
- Xueyun Huo
- Zhenkun Li
- Shuangyue Zhang
- Changlong Li
- Meng Guo
- Jing Lu
- Jianyi Lv
- Xiaoyan Du
- Zhenwen Chen
View Affiliations

Affiliations: Department of Medical Genetics, School of Basic Medical Science, Capital Medical University, Beijing 100069, P.R. China
Published online on: August 4, 2017 https://doi.org/10.3892/ol.2017.6721
Pages: 4339-4348

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tumorigenesis is often caused by somatic mutation or epigenetic changes in genes that regulate aspects of cell death, proliferation and survival. Although the functions of multiple tumor suppressor genes have been well studied in isolation, how these genes cooperate during the progression of a single tumor remains unclear in numerous cases. The present study used N‑methyl‑N‑nitrosourea (MNU), one of the most potent mutagenic nitrosourea compounds, to induce thymic lymphoma in C57BL/6J mice. Subsequently, the protein expression levels of phosphatase and tensin homolog (PTEN), transformation protein 53 and mutS homolog 2 (MSH2) were evaluated concomitantly in the thymus, liver, kidney and spleen of MNU‑treated mice by western blotting. To determine whether changes in expression level were due to aberrant epigenetic regulation, the present study further examined the methylation status of each gene by MassARRAY analysis. During the tumorigenesis process of an MNU‑induced single thymic lymphoma, the expression level of PTEN was revealed to be reduced in thymic lymphoma samples but not in normal or non‑tumor thymus tissue samples. Furthermore, a marked reduction of P53 expression levels were demonstrated in thymic lymphomas and spleens with a metastatic tumor. Conversely, MSH2 upregulation was identified only in liver, kidney, and spleen samples that were infiltrated by thymic lymphoma cells. Furthermore, the present study revealed that a number of 5'‑C‑phosphate‑G‑3' sites located in the promoter of aberrantly expressed genes had significantly altered methylation statuses. These results improve the understanding of the course of mutagen‑induced cancer, and highlight that epigenetic regulation may serve an important function in cancer.

View Figures

View References

1	Han SW, Lee HJ, Bae JM, Cho NY, Lee KH, Kim TY, Oh DY, Im SA, Bang YJ, Jeong SY, et al: Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer. Int J Cancer. 132:2209–2216. 2013. View Article : Google Scholar : PubMed/NCBI
2	Salmena L, Carracedo A and Pandolfi PP: Tenets of PTEN tumor suppression. Cell. 133:403–414. 2008. View Article : Google Scholar : PubMed/NCBI
3	Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, Baer R and Gu W: Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell. 149:1269–1283. 2012. View Article : Google Scholar : PubMed/NCBI
4	Vazquez F and Devreotes P: Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction. Cell Cycle. 5:1523–1527. 2006. View Article : Google Scholar : PubMed/NCBI
5	Vousden KH and Prives C: P53 and prognosis: New insights and further complexity. Cell. 120:7–10. 2005. View Article : Google Scholar : PubMed/NCBI
6	Soria JC, Lee HY, Lee JI, Wang L, Issa JP, Kemp BL, Liu DD, Kurie JM, Mao L and Khuri FR: Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res. 8:1178–1184. 2002.PubMed/NCBI
7	Jesionek-Kupnicka D, Szybka M, Malachowska B, Fendler W, Potemski P, Piaskowski S, Jaskolski D, Papierz W, Skowronski W, Och W, et al: TP53 promoter methylation in primary glioblastoma: Relationship with TP53 mRNA and protein expression and mutation status. Dna Cell BioL. 33:217–226. 2014. View Article : Google Scholar : PubMed/NCBI
8	Zeng X and Kinsella TJ: A novel role for DNA mismatch repair and the autophagic processing of chemotherapy drugs in human tumor cells. Autophagy. 3:368–370. 2007. View Article : Google Scholar : PubMed/NCBI
9	Harfe BD and Jinks-Robertson S: Sequence composition and context effects on the generation and repair of frameshift intermediates in mononucleotide runs in Saccharomyces cerevisiae. Genetics. 156:571–578. 2000.PubMed/NCBI
10	Campbell MR, Wang Y, Andrew SE and Liu Y: Msh2 deficiency leads to chromosomal abnormalities, centrosome amplification, and telomere capping defect. Oncogene. 25:2531–2536. 2006. View Article : Google Scholar : PubMed/NCBI
11	Song W, Liu Y, Liu Y, Zhang C, Yuan B, Zhang L and Sun S: Increased P16 DNA methylation in mouse thymic lymphoma induced by irradiation. PLoS One. 9:e938502014. View Article : Google Scholar : PubMed/NCBI
12	Douet V, Heller MB and Le Saux O: DNA methylation and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter. Biochem Biophys Res Commun. 354:66–71. 2007. View Article : Google Scholar : PubMed/NCBI
13	Suzuki MM and Bird A: DNA methylation landscapes: Provocative insights from epigenomics. Nat Rev Genet. 9:465–476. 2008. View Article : Google Scholar : PubMed/NCBI
14	Nishida N and Kudo M: Alteration of epigenetic profile in human hepatocellular carcinoma and its clinical implications. Liver Cancer. 3:417–427. 2014. View Article : Google Scholar : PubMed/NCBI
15	Singla N and Dhawan DK: N-methyl N-nitrosourea induced functional and structural alterations in mice brain-role of curcumin. Neurotox Res. 22:115–126. 2012. View Article : Google Scholar : PubMed/NCBI
16	Chang YC, Hsu JD, Lin WL, Lee YJ and Wang CJ: High incidence of acute promyelocytic leukemia specifically induced by N-nitroso-N-methylurea (NMU) in Sprague-Dawley rats. Arch Toxicol. 86:315–327. 2012. View Article : Google Scholar : PubMed/NCBI
17	Huo X, Zhang S, Li Z, Gao J, Wang C, Li C, Guo M, Du X and Chen Z: Analysis of the relationship between microsatellite instability and thymic lymphoma induced by N-methyl-N-nitrosourea in C57BL/6J mice. Mutat Res. 771:21–28. 2015. View Article : Google Scholar : PubMed/NCBI
18	Coolen MW, Statham AL, Gardiner-Garden M and Clark SJ: Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: Critical evaluation and improvements. Nucleic Acids Res. 35:e1192007. View Article : Google Scholar : PubMed/NCBI
19	Otozai S, Ishikawa-Fujiwara T, Oda S, Kamei Y, Ryo H, Sato A, Nomura T, Mitani H, Tsujimura T, Inohara H and Todo T: p53-Dependent suppression of genome instability in germ cells. Mutat Res. 760:24–32. 2014. View Article : Google Scholar : PubMed/NCBI
20	Kamimura K, Ohi H, Kubota T, Okazuka K, Yoshikai Y, Wakabayashi Y, Aoyagi Y, Mishima Y and Kominami R: Haploinsufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development. Biochem Biophys Res Commun. 355:538–542. 2007. View Article : Google Scholar : PubMed/NCBI
21	Guo W, Schubbert S, Chen JY, Valamehr B, Mosessian S, Shi H, Dang NH, Garcia C, Theodoro MF, Varella-Garcia M and Wu H: Suppression of leukemia development caused by PTEN loss. Proc Natl Acad Sci USA. 108:1409–1414. 2011. View Article : Google Scholar : PubMed/NCBI
22	Buckler JL, Walsh PT, Porrett PM, Choi Y and Turka LA: Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN. J Immunol. 177:4262–4266. 2006. View Article : Google Scholar : PubMed/NCBI
23	Hagenbeek TJ and Spits H: T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus. Leukemia. 22:608–619. 2008. View Article : Google Scholar : PubMed/NCBI
24	Suzuki A, Yamaguchi MT, Ohteki T, Sasaki T, Kaisho T, Kimura Y, Yoshida R, Wakeham A, Higuchi T, Fukumoto M, et al: T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity. 14:523–534. 2001. View Article : Google Scholar : PubMed/NCBI
25	Xue L, Nolla H, Suzuki A, Mak TW and Winoto A: Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice. Proc Natl Acad Sci USA. 105:2022–2027. 2008. View Article : Google Scholar : PubMed/NCBI